{"id":27826,"date":"2022-05-25T09:00:54","date_gmt":"2022-05-25T04:00:54","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=92274"},"modified":"2022-05-25T09:00:54","modified_gmt":"2022-05-25T04:00:54","slug":"rensselaer-polytechnic-institute-and-icahn-school-of-medicine-at-mount-sinai-announce-joint-center-for-engineering-and-precision-medicine-in-new-york-city","status":"publish","type":"post","link":"https:\/\/myanmarnewsgazette.com\/rensselaer-polytechnic-institute-and-icahn-school-of-medicine-at-mount-sinai-announce-joint-center-for-engineering-and-precision-medicine-in-new-york-city\/","title":{"rendered":"Rensselaer Polytechnic Institute and Icahn School of Medicine at Mount Sinai Announce Joint Center for Engineering and Precision Medicine in New York City"},"content":{"rendered":"
\n

NEW YORK, May 24, 2022 (GLOBE NEWSWIRE) — Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai recently announced the creation of the Center for Engineering and Precision Medicine<\/a> (CEPM), one of the first centers in the nation to bridge engineering and engineering science with medicine. This undertaking will build on a wealth of shared basic research discoveries, explore unique therapeutic innovations in cancer, Alzheimer\u2019s, infectious diseases; and tissue degeneration; educate a new generation of biomedical leaders; and develop new technologies and processes that enhance patient outcomes in unprecedented ways. CEPM represents an evolution in the successful partnership between Mount Sinai and RPI, one that has secured over $70 million in shared research funding since 2013 with 90 percent of that provided by the National Institutes of Health.<\/p>\n

The joint center located at 619 West 54th<\/sup> Street in Manhattan, will drive advances in point-of-care and point-of-use devices and diagnostics; microphysiological platforms for discovery and diagnosis; robotic surgery;\u00a0biomedical imaging; therapeutics biomanufacturing; and\u00a0artificial intelligence and machine learning applied to biomedical data. These engineering advances will improve patients\u2019 quality of life by synergizing state-of-the-art expertise in research and education at the nexus of engineering and medicine.<\/p>\n

The center was announced with a ceremonial signing at the new site.<\/p>\n

\u201cThis transformative partnership between Rensselaer and Icahn Mount Sinai recognizes that engineering and engineering science is fundamental to the understanding of biomedical phenomena and is essential to the development of the next generation of precision diagnostics and therapeutics, human health and well-being, and to the training of advanced researchers and physicians,\u201d said Shirley Ann Jackson, PhD<\/a>, President of Rensselaer Polytechnic Institute. <\/a>\u201cInnovative research is a foundation of Rensselaer, as our students, faculty, and graduates continue to change the world through scientific and technological advances. This center will continue to fuel medical and scientific discoveries with life-changing impacts across the globe.\u201d\"RENSSELAER<\/a><\/p>\n

\u201cFrom highly sensitive and accurate bioimaging systems to new drug target discoveries, the major inventions that have shaped modern medicine were born out of close collaboration between engineers and clinicians,\u201d said Dennis S. Charney, MD<\/a>, Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai and President for Academic Affairs of the Mount Sinai Health System. \u201cThe CEPM presents a bold new paradigm for that collaboration to continue that we believe will result in unprecedented advances in science, medicine, and human health. In addition, the PhD program will enable us to attract and equip a new generation of researchers with the interdisciplinary engineering and clinical skills to pursue more groundbreaking, impactful research.\u201d<\/p>\n

The Center for Engineering and Precision Medicine grew out of the historically collaborative work by Rensselaer and Icahn Mount Sinai researchers in the field of precision medicine, a personalized approach to disease treatment and prevention based on individuals\u2019 biological, environmental, and lifestyle differences. The CEPM will develop new technologies that will revolutionize the way patient care is delivered.<\/p>\n

\u201cEngineering is the driving force for an increasing number of important medical breakthroughs,\u201d said Jonathan Dordick, PhD<\/a>, Institute Professor of Chemical and Biological Engineering at Rensselaer and Co-Director of CEPM. \u201cThe joint Center for Engineering and Precision Medicine is ideally positioned to integrate engineering research and education with medicine to develop new diagnostics and treatments at the individual level, making a real difference in people\u2019s lives.\u201d<\/p>\n

\u201cUltimately, the outcome of CEPM will be new, transformative research projects and innovative technologies that shift clinical paradigms,\u201d said Priti Balchandani, PhD<\/a>,\u00a0Professor of Diagnostic, Molecular and Interventional Radiology, Neuroscience, and Psychiatry at Icahn Mount Sinai and Co-Director of CEPM. \u201cAnd we believe this collaboration will generate new start-ups and attract commercial partners who transform the technologies we pioneer into therapeutic solutions that improve health care and have life-changing outcomes for our patients and for society as a whole.\u201d<\/p>\n

\u201cThe life sciences sector is at the center of New York\u2019s economic and public health future, and this project represents an important step forward toward that future,\u201d said New York City Mayor Eric Adams. \u201cI want to thank Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai for their steadfast commitment to New York City. I look forward to the many critical innovations they will produce together.\u201d<\/p>\n

\u201cThanks to the innovative and historic partnership of Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mt. Sinai, the\u00a0new\u00a0Center for Engineering and Precision Medicine holds tremendous promise for biomedicine.\u00a0The Center is part of the expanding and important biotech industry which is critical to our economy and the health of all New Yorkers and Americans. I look forward to supporting the Center for Engineering and Precision Medicine as it grows and makes major contributions to society,\u201d said Congressman Jerrold Nadler.<\/p>\n

\u201cThis Center will revolutionize medical practices for some of our most devastating diseases. At the core of the City\u2019s vision for life sciences is creating opportunity for all New Yorkers, which our Mayor is working so hard to address. We have an opportunity to welcome Rensselaer Polytechnic Institute to New York City, and with world-class partner, Mount Sinai, watch them change research, make discoveries, and ultimately improve patient care, saving lives,\u201d said\u00a0Deputy Mayor for Economic and Workforce Development Maria Torres-Springer.<\/p>\n

\u201cIt\u2019s about helping treat people who are sick and improve the lives and care of New Yorkers,\u201d s<\/strong>aid New York City Economic Development Corporation President and CEO Andrew Kimball. \u201cNew York City is proud to have these leading institutions growing innovation around life sciences on the West Side of Manhattan and helping us put the City on a path to strengthening our future talent. Ultimately, NYCEDC\u2019s goal, like this Center, is to spur new research and develop our talent to translate to new companies, jobs, medicines, and advanced technologies. As the Center continues to expand, we\u2019re excited at the prospect of partnership ahead.\u201d<\/p>\n

Rensselaer Polytechnic Institute is the first and one of the most renowned technological research universities in the nation. Rensselaer researchers are internationally recognized for their expertise in biotechnology and biomanufacturing; neuromodulation; tissue engineering, biocomputation, robotics, devices and microfabrication; and artificial intelligence, machine learning, and high-performance computing.<\/p>\n

Icahn Mount Sinai is the academic arm of the Mount Sinai Health System, which offers premier medical and research training and education, runs clinical trials with data available from nearly 4 million patients, and translates basic and biomedical research into commercial products.<\/p>\n

The CEPM will focus on three critical research areas at the interface of engineering and medicine:<\/p>\n